BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7907608)

  • 21. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases.
    Paraf F; Fléjou JF; Pignon JP; Fékété F; Potet F
    Am J Surg Pathol; 1995 Feb; 19(2):183-91. PubMed ID: 7832278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferating cell nuclear antigen in the assessment of Barrett's mucosa.
    Gillen P; McDermott M; Grehan D; Hourihane DO; Hennessy TP
    Br J Surg; 1994 Dec; 81(12):1766-8. PubMed ID: 7827934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: a comparative study.
    Whittles CE; Biddlestone LR; Burton A; Barr H; Jankowski JA; Warner PJ; Shepherd NA
    J Pathol; 1999 Apr; 187(5):535-40. PubMed ID: 10398118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry.
    Laerum OD; Ovrebo K; Skarstein A; Christensen IJ; Alpízar-Alpízar W; Helgeland L; Danø K; Nielsen BS; Illemann M
    Int J Cancer; 2012 Aug; 131(3):558-69. PubMed ID: 21866548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
    Hardwick RH; Shepherd NA; Moorghen M; Newcomb PV; Alderson D
    J Clin Pathol; 1995 Feb; 48(2):129-32. PubMed ID: 7745111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions.
    Choy B; LaLonde A; Que J; Wu T; Zhou Z
    Hum Pathol; 2016 Nov; 57():126-135. PubMed ID: 27476776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal metaplasia in Barrett's oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett's tumour.
    Watanabe G; Ajioka Y; Takeuchi M; Annenkov A; Kato T; Watanabe K; Tani Y; Ikegami K; Yokota Y; Fukuda M
    Histopathology; 2015 Jan; 66(2):201-14. PubMed ID: 25040564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus.
    Nishigaki H; Wada K; Tatsuguchi A; Sueoka N; Futagami S; Gudis K; Miyake K; Tsukui T; Sakamoto C
    Digestion; 2004; 70(2):95-102. PubMed ID: 15375338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
    Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.
    Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG
    Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma.
    Jankowski J; Hopwood D; Wormsley KG
    Scand J Gastroenterol; 1992; 27(2):147-54. PubMed ID: 1348589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathological characteristics of Barrett's carcinoma, cardia carcinoma type II and distal gastric carcinoma: influence of observed parameters on the five-year postoperative survival of patients].
    Jovanović I; Alempijević T; Milosavljević T; Popović D; Bjelović M; Micev M; Pesko P
    Srp Arh Celok Lek; 2009; 137(5-6):249-54. PubMed ID: 19594065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett's neoplasia.
    Iravani S; Zhang HQ; Yuan ZQ; Cheng JQ; Karl RC; Jove R; Coppola D
    Hum Pathol; 2003 Oct; 34(10):975-82. PubMed ID: 14608530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
    Asthana N; Mandich D; Ligato S
    Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.